Skip to main content

Omid Farokhzad, M.D.

Equibles does not estimate personal net worth.

About Omid Farokhzad, M.D.

Seer, Inc. reported in an 8-K filed September 18, 2026 that Omid Farokhzad, M.D. was appointed President, effective October 1, 2026. Seer, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Seer, Inc. includes Omid Farokhzad (CEO and Board Member), Charles Endweiss (CFO and Chief Accounting Officer), Elona Kogan (General Counsel) and 7 others.

“on September 17, 2026, the Board appointed Omid Farokhzad, M.D. to the office of President of the Company, in addition to his current positions as Chief Executive Officer and Chair of the Board, and Charles Endweiss, Vice President, Financial Planning & Analysis of the Company as Treasurer of the Company, each effective as of October 1, 2026.”
Seer, Inc. Form 8-K, filed September 18, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Seer, Inc.

Recent activity